Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2012

01.12.2012 | Original Article

Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus

verfasst von: K. N. Pannag Desai, M. S. Roopakala, C. R. Wilma Delphine Silvia, K. M. Prasanna Kumar

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to assess the plasma fibrinogen levels in type 2 diabetes mellitus patients and to compare with that of healthy controls. To correlate plasma fibrinogen levels with blood pressure (BP), BMI (Body Mass Index) and HbA1c (Glycated hemoglobin) among diabetics and healthy controls. Blood samples were collected for Plasma fibrinogen levels and HbA1c from 30 diagnosed type 2 diabetes mellitus patients. Their BP and BMI were recorded. 30 age and sex matched healthy subjects were included as a control group. There was a rise in plasma fibrinogen levels in diabetics with BMI < 25 kg/m2 as compared to controls of the same BMI group (P = 0.097). Also, there was a trend of raised plasma fibrinogen levels among male diabetics as compared to male control subjects (P = 0.079). However, there appears no such difference among female individuals. However, there was no significant correlation between fibrinogen levels, blood pressure and HbA1c both among controls and diabetic cases (P >0.05). Though there was a slight trend of increasing levels of plasma fibrinogen among diabetics as compared to controls. However, a significant positive correlation between BMI, male gender and increasing age with plasma fibrinogen was found.
Literatur
1.
Zurück zum Zitat Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853–76.PubMed Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853–76.PubMed
2.
Zurück zum Zitat Guerci B, Kearney-Schwartz A. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab. 2001;27:425–34.PubMed Guerci B, Kearney-Schwartz A. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab. 2001;27:425–34.PubMed
3.
Zurück zum Zitat Avogaro A, Kreutzenberg SV. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008;15:S94–101.CrossRef Avogaro A, Kreutzenberg SV. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008;15:S94–101.CrossRef
4.
Zurück zum Zitat Le DS, Miles R. The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes. Haematolgia. 2008;82:317–23. Le DS, Miles R. The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes. Haematolgia. 2008;82:317–23.
5.
Zurück zum Zitat Panwar RB, Gupta R. Atherothrombotic risk factors & premature coronary heart disease in India: a case–control study. Indian J Med Res. 2011;134:26–32.PubMed Panwar RB, Gupta R. Atherothrombotic risk factors & premature coronary heart disease in India: a case–control study. Indian J Med Res. 2011;134:26–32.PubMed
6.
Zurück zum Zitat Chugh SN, Dabla S. Evaluation of endothelial function and effect of glycemic control (excellent vs. poor/fair control) on endothelial function in uncontrolled type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:478–80.PubMed Chugh SN, Dabla S. Evaluation of endothelial function and effect of glycemic control (excellent vs. poor/fair control) on endothelial function in uncontrolled type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:478–80.PubMed
7.
Zurück zum Zitat Aboul Ella NA, Sheehab D. Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age. J Clin Lipidol. 2010;4:185–95.PubMedCrossRef Aboul Ella NA, Sheehab D. Prevalence of metabolic syndrome and insulin resistance among Egyptian adolescents 10 to 18 years of age. J Clin Lipidol. 2010;4:185–95.PubMedCrossRef
8.
Zurück zum Zitat Pieters M, Van Zyl DG. Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation. Thromb Res. 2007;120:439–46.PubMedCrossRef Pieters M, Van Zyl DG. Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation. Thromb Res. 2007;120:439–46.PubMedCrossRef
9.
Zurück zum Zitat Langouche L, Meersseman W. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med. 2008;36:1475–80.PubMedCrossRef Langouche L, Meersseman W. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Crit Care Med. 2008;36:1475–80.PubMedCrossRef
Metadaten
Titel
Evaluation of plasma fibrinogen levels in type 2 diabetes mellitus
verfasst von
K. N. Pannag Desai
M. S. Roopakala
C. R. Wilma Delphine Silvia
K. M. Prasanna Kumar
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2012
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-012-0093-z

Weitere Artikel der Ausgabe 4/2012

International Journal of Diabetes in Developing Countries 4/2012 Zur Ausgabe